Company intelligence / Profile preview

Akylox Therapeutics GmbH

Basel, Basel-Stadt, Switzerlandpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Preclinical

Overview

Akylox Therapeutics GmbH is a Swiss biotech/pharma company focused on the development and commercialization of pharmaceutical active ingredients and technologies for their development. The company was founded in October 2024 and operates out of Basel, Switzerland. Further details about clinical results are not publicly available as of May 2025.

Industry: Biotech

Drug pipeline

1 asset

compound 9

Pre-clinical

Indications: PI3Kα-mutant cancers

Beyond the preview

Go deeper on Akylox Therapeutics GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akylox Therapeutics GmbH.

Explore the full profile